, Tracking Stock Market Picks
Enter Symbol:
St. Jude Medical, Inc. (STJ) [hlAlert]

up 73.90 %

St. Jude Medical, Inc. (STJ) rated Buy with price target $35 by Deutsche Securities

Posted on: Wednesday,  Jan 28, 2009  1:25 PM ET by Deutsche Securities

Deutsche Securities rated Buy St. Jude Medical, Inc. (NYSE: STJ) on 01/28/2009. Previously Deutsche Securities rated Buy St. Jude Medical, Inc. (NYSE: STJ)
on 01/24/2008., when the stock price was $41.65. Since then, St. Jude Medical, Inc. has gained 73.90% as of 01/28/2016's recent price of $72.43.
If you would have followed the previous Deutsche Securities's recommendation on STJ, you would have gained 73.9% of your investment in 2926 days.

St. Jude Medical, Inc. (St. Jude)develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiology and cardiac surgery and atrial fibrillation therapy areas and implantable neurostimulation devices for the management of chronic pain. The Company operates in four business segments: Cardiac Rhythm Management (CRM), Cardiovascular (CV), Atrial Fibrillation (AF) and Neuromodulation Systems (Neuro). On July 3, 2008, the Company completed the acquisition of EP MedSystems, Inc. On December 19, 2008, St. Jude acquired Radi Medical Systems. On December 22, 2008, St. Jude acquired MediGuide Inc.

Deutsche Bank's award-winning Research team manages a range of functions from asset allocation, through economic forecasting across a broad range of industry sectors including cement and construction, chemicals, electronics, energy, engineering, machinery, media, software, tobacco, retailing and utilities, and oil and gas.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/28/2009 1:25 PM Buy
35.18 35.00
as of 12/31/2009
1 Week up  15.46 %
1 Month up  15.93 %
3 Months up  9.10 %
1 YTD up  29.12 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/24/2008 2:25 PM Buy
41.65 48.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy